American International Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-28,149
| Closed | -$814K | – | 2068 |
|
2024
Q1 | $814K | Sell |
28,149
-241
| -0.8% | -$6.97K | ﹤0.01% | 1408 |
|
2023
Q4 | $651K | Sell |
28,390
-115
| -0.4% | -$2.64K | ﹤0.01% | 1517 |
|
2023
Q3 | $475K | Buy |
28,505
+2,411
| +9% | +$40.2K | ﹤0.01% | 1639 |
|
2023
Q2 | $721K | Buy |
26,094
+3,638
| +16% | +$100K | ﹤0.01% | 1431 |
|
2023
Q1 | $516K | Buy |
22,456
+447
| +2% | +$10.3K | ﹤0.01% | 1587 |
|
2022
Q4 | $240K | Buy |
22,009
+164
| +0.8% | +$1.79K | ﹤0.01% | 2038 |
|
2022
Q3 | $184K | Buy |
21,845
+308
| +1% | +$2.59K | ﹤0.01% | 2201 |
|
2022
Q2 | $170K | Sell |
21,537
-673
| -3% | -$5.31K | ﹤0.01% | 2297 |
|
2022
Q1 | $526K | Sell |
22,210
-1,562
| -7% | -$37K | ﹤0.01% | 1693 |
|
2021
Q4 | $813K | Sell |
23,772
-711
| -3% | -$24.3K | ﹤0.01% | 1538 |
|
2021
Q3 | $434K | Buy |
24,483
+1,318
| +6% | +$23.4K | ﹤0.01% | 1956 |
|
2021
Q2 | $1.04K | Buy |
23,165
+2,638
| +13% | +$118 | ﹤0.01% | 1493 |
|
2021
Q1 | $532 | Buy |
20,527
+2,224
| +12% | +$58 | ﹤0.01% | 1802 |
|
2020
Q4 | $369 | Buy |
18,303
+188
| +1% | +$4 | ﹤0.01% | 1924 |
|
2020
Q3 | $354K | Buy |
18,115
+4,306
| +31% | +$84.1K | ﹤0.01% | 1784 |
|
2020
Q2 | $244K | Buy |
13,809
+3,370
| +32% | +$59.5K | ﹤0.01% | 2011 |
|
2020
Q1 | $74K | Sell |
10,439
-602
| -5% | -$4.27K | ﹤0.01% | 2490 |
|
2019
Q4 | $78K | Buy |
11,041
+286
| +3% | +$2.02K | ﹤0.01% | 2741 |
|
2019
Q3 | $129K | Buy |
10,755
+1,113
| +12% | +$13.4K | ﹤0.01% | 2449 |
|
2019
Q2 | $117K | Buy |
+9,642
| New | +$117K | ﹤0.01% | 2587 |
|
2018
Q2 | – | Sell |
-7,285
| Closed | -$63K | – | 3108 |
|
2018
Q1 | $63K | Sell |
7,285
-392
| -5% | -$3.39K | ﹤0.01% | 2842 |
|
2017
Q4 | $160K | Buy |
7,677
+1,389
| +22% | +$28.9K | ﹤0.01% | 2455 |
|
2017
Q3 | $111K | Buy |
6,288
+470
| +8% | +$8.3K | ﹤0.01% | 2612 |
|
2017
Q2 | $66K | Buy |
5,818
+1,254
| +27% | +$14.2K | ﹤0.01% | 2921 |
|
2017
Q1 | $58K | Buy |
+4,564
| New | +$58K | ﹤0.01% | 2799 |
|